Article thumbnail

Stereotactic Body Radiation Therapy Is Effective and Safe in Patients with Early-Stage Non-Small Cell Lung Cancer with Low Performance Status and Severe Comorbidity

By Martin Turzer, Odd Terje Brustugun, Einar Waldeland and Åslaug Helland
Topics: Published: January 2011
Publisher: S. Karger AG
OAI identifier: oai:pubmedcentral.nih.gov:3082486
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. al: Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
  2. (1996). al: Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?
  3. (2009). al: Radiochemotherapy in the elderly with lung cancer. Expert Rev Anticancer Ther
  4. (2009). al: Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol
  5. al: Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung cancer 2003;40:309–315.
  6. (2005). al: Surgery for early stage non-small cell lung cancer. Cochrane Database Syst Rev
  7. Antonisse ME: Stage I nonsmall cell lung cancer in patients aged > or = 75 years: outcomes after stereotactic radiotherapy.
  8. Beattie EJ: Results of surgical treatment in stage I lung cancer.
  9. (1998). Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer
  10. DP: The National cancer data base report on lung cancer.
  11. et al: Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience.
  12. et al: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I nonsmall cell lung cancer: updated results of 257 patients in a japanese multi-institutional study.
  13. et al: Local recurrence after surgery for early stage lung cancer: an 11-year experience with 975 patients.
  14. (1991). et al: Long-term postthoracotomy pain.
  15. et al: Outcome in a prospective phase II trial of medically inoperable stage I non-small cell lung cancer patients treated with stereotactic body radiotherapy.
  16. et al: Prospective evaluation of early lung toxicity following threedimensional conformal radiation therapy in non-small cell lung cancer: preliminary results.
  17. (1993). et al: Radiation therapy alone for stage I non-small cell lung cancer.
  18. et al: Stereotactic radiotherapy of malignancies in the abdomen.
  19. (1991). GM: Localized adenocarcinoma of the lung: a retrospective study of 186 nonmetastatic patients from the French Federation of Cancer Institutes-the Radiotherapy Cooperative Group.
  20. KL: The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep 2010;12:235–241.
  21. Radiation-induced rib fractures after hypofractionated body radiation therapy of non-small cell lung cancer: A dose- and volume-response analysis. Radiotherapy and Oncology
  22. Radiotherapy for patients with medically inoperable stage I non-small cell lung cancer.
  23. Rep Oncol 2011;4:25–34
  24. Saunders MI: Continuous, hyperfractionated, accelerated radiotherapy (CHART).
  25. (2006). Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer
  26. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer.